|
US6320041B1
(en)
|
2001-04-13 |
2001-11-20 |
Trilink Biotechnologies, Inc. |
Pre-activated carbonyl linkers for the modification of oligonucleotides
|
|
EP3006043B1
(en)
|
2002-04-04 |
2019-05-29 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
JP2007526253A
(ja)
*
|
2004-02-19 |
2007-09-13 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
免疫刺激性ウイルスｒｎａオリゴヌクレオチド
|
|
EP1819226A4
(en)
*
|
2004-12-08 |
2010-12-29 |
3M Innovative Properties Co |
COMBINATIONS AND METHODS OF IMMUNOSTIMULATION
|
|
US8003619B2
(en)
|
2004-12-09 |
2011-08-23 |
Alnylam Pharmaceuticals, Inc. |
Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide
|
|
US20080009455A9
(en)
*
|
2005-02-24 |
2008-01-10 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory oligonucleotides
|
|
EP1924284A1
(en)
|
2005-09-14 |
2008-05-28 |
Hartmann, Gunther |
Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides
|
|
EP1764107A1
(en)
*
|
2005-09-14 |
2007-03-21 |
Gunther Hartmann |
Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides
|
|
WO2007038720A2
(en)
*
|
2005-09-27 |
2007-04-05 |
Coley Pharmaceutical Gmbh |
Modulation of tlr-mediated immune responses using adaptor oligonucleotides
|
|
JP4538522B2
(ja)
*
|
2005-11-25 |
2010-09-08 |
コーリー ファーマシューティカル ゲーエムベーハー |
免疫刺激性オリゴリボヌクレオチド
|
|
CN101331229B
(zh)
*
|
2005-11-25 |
2012-08-29 |
科勒制药股份公司 |
免疫刺激性寡核糖核苷酸
|
|
KR101221589B1
(ko)
*
|
2006-04-07 |
2013-01-15 |
이데라 파마슈티칼즈, 인코포레이티드 |
Ｔｌｒ７ 및 ｔｌｒ８에 대한 안정화된 면역 조절성 ｒｎａ〔ｓｉｍｒａ〕 화합물
|
|
ATE502122T1
(de)
|
2006-06-01 |
2011-04-15 |
Trilink Biotechnologies |
Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
|
|
EP2046954A2
(en)
*
|
2006-07-31 |
2009-04-15 |
Curevac GmbH |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
|
ES2911034T3
(es)
*
|
2006-08-08 |
2022-05-17 |
Univ Bonn Rheinische Friedrich Wilhelms |
Estructura y uso de oligonucleótidos 5' fosfato
|
|
US20080171716A1
(en)
|
2006-08-16 |
2008-07-17 |
Protiva Biotherapeutics, Inc. |
Nucleic acid modulation of toll-like receptor-mediated immune stimulation
|
|
EP2357231A2
(en)
*
|
2007-07-09 |
2011-08-17 |
Idera Pharmaceuticals, Inc. |
Stabilized immune modulatory RNA (SIMRA) compounds
|
|
CA2704853C
(en)
*
|
2007-11-06 |
2017-08-15 |
Eugen Uhlmann |
Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
|
|
US20100047188A1
(en)
*
|
2008-08-04 |
2010-02-25 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 8 expression by antisense oligonucleotides
|
|
US9631227B2
(en)
|
2009-07-06 |
2017-04-25 |
Trilink Biotechnologies, Inc. |
Chemically modified ligase cofactors, donors and acceptors
|
|
WO2016040589A1
(en)
*
|
2014-09-12 |
2016-03-17 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting complement component c5 and methods of use thereof
|
|
EP3310918B1
(en)
*
|
2015-06-18 |
2020-08-05 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
|
|
CN120842296A
(zh)
|
2015-09-21 |
2025-10-28 |
垂林克生物技术有限公司 |
用于合成5’-加帽rna的组合物和方法
|
|
WO2017100587A1
(en)
*
|
2015-12-09 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting programmed cell death 1 ligand 1 (pd-l1) and methods of use thereof
|
|
WO2018184003A1
(en)
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Modulating dsrna editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon
|
|
JP2020522510A
(ja)
*
|
2017-06-02 |
2020-07-30 |
ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． |
オリゴヌクレオチド組成物及びその使用方法
|
|
KR20230013266A
(ko)
|
2020-05-19 |
2023-01-26 |
허드슨 인스티튜트 오브 메디컬 리서치 |
올리고뉴클레오티드
|